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A sentinel surveillance study was carried out to monitor the incidence of hand, fool and Patio Mac 1998 hingga 0 
diseuse (HFMD) in Sarawnk, Malaysia from March 1998 through August 1999. This study ~volved pmyoki' ,angan. kaki dan I 
participation of seven sentinel clinics located in Kuching, Sibu, Miri and Sarikei. Children who ......... 7 buah 1dinik ,erpilih d 
~linically diagnosed with HFMD were included in the study and the collected clinical specimens 
mocuIated onto the human rhabdomyosarcoma (RD) cells for the isolation of enteroviruses. The 
of enterovirus RNA in the culture fluids WIIS confirmed with RT -PCR using pan-EV primer univcrsal 
enterovirus. The temporal distribution of HFMD shows an epidemiological paUern of HFMD 
where ~~. in July, August and September 1998. The absence of these peaks . 
corresponding pmod m 1999 suggests that occurrence of HFMD in Sarawak may not be seasonal. 
HFMD p~ were ~so s~ in April, November 1998 and March 1999. The clinical descriptioD 
HFMD m Sarawak did not differ from the classic descriptions of HFMD, and the characteristic of 
and non-EV71 HFMD were also shown to be similar. 
The incidence specifically of EV71 HFMD was also studied. Culture fluids from 
positive children were subjected to RT-PCR using EV71 specific primer. The result shows that EV7 J 
detected during the period of April to September 1998. The monthly rate of EV71 detection 
belween 5-20%. Overall, the rate of EV71 isolation during the surveillance period was only 
phylogenetic,analysis based on the partial VPl nucleotide sequences shows that the EV71 strains . 
during the surveillance period in 1998 belong to genogroup C. These Sarawnk 1998 strains 
found to be closely related to three of the four Taiwan 1998 strains. One of the Taiwan strains 
genogroup B. Phylogenetic analysis of EV71 strains isolated during HFMD outbreak in Sarawak in 
reveals that the strains were of B-type. The Sarawak 1997 EV71 strains isolated from gcx)gJ'llphicaq 
~~ent fO\vns in Sarawak were genetically similar and tightly clustered into an independent 
Within the genogroup B. The phylogenetic study of EV71 strains circulating in Sarawak and Taiwan 





dengan primer 'pan-E 
temporal ,elah mendap
0Jdr and Sep,ember. 1998. 
,.. IfIQ.fO yang sama pal 
lidak bermusim eli Sa] 
April. November I ~ 
darlpadD sija,-si/a, ~ 
tUapali "dok berbeza doripa 
l1I8I'" HFMD yang dis 
-.s yang klah dilunjukkan 1 
,._lIftlr upadD EV71 dengan 
diuson dolam jangka 
..... dori 5% hinggo
..,1fGIl" pDlyaki, HFMD han;1 
_.~m daripada gen JIi 
IJIIJb upado 'genogroup C l 
1998 EJl71 mendapati bOli 
lagi berada di dolam ' I 
wa6ak HFMD di Sarawak 
1997 EV71 yang diasingki 
dan ia membentuk Jd 
)ItIIIg dtperolehi di Sarawak . 
..,1Iki oleh genogroup yang 
PadaMac 1998 hingga Ogos 1999, satu pengawasan kawalan telah dijalankon untllk mengkoji 
tbIII(lujiden penyakit tangan, koki dan mltlut (HFMD) di Sarawak, MalO)'$ia, Kajian ini telah meltbatkan 
wcre_ J'r'trtaan 7 buah klinik terpilih di Kuching, Sibil, Mirl dan Sarlkei, Spesimen klinikol telah diambil 
kanak-konak yang disyaki mengidap penyalcit HFMD dan dimasukkan ke dalam sel 
prc:sell~ItIJ'a/xtoll1~tarc~onla unhlk pengasingan enterovints. Kehadiran semua RNA enterovirus di da/am kultur 
dengan prlmer 'pan-EV' dengan menggunakon koedah RT-PCR. . Pemerlhaan terhadap 
~iCIoIlINrnt,rbUlran temporal telah mendapati bi/angan kes HFMD meningkot secora mend adak di dalam bulan 
tlMIik"rJtJi. Ogo.s and September, 1998. Walaubagaimanapun. peningkotan di dalam bilangan kes tidak 
......."''''". Mrin(.~"Qku patio masa yang sama pada tahun 1999 dan berdasarkon kesimpulan ini. HFMD mungkin 
aIII~l)aJ~t yong tidak bermusim di Sarawak. Peningkatan minor di dalam bi/angan kes juga diperhatikan 
hulon April, November 1998 dan Mac 1999. Sifat-sifat Idinikol HFMD di Sarawak didapati 
berbezo daripada sifat-sifat k1asik HFMD. Sifat-sifat k1inikol HFMD yang disebabkan oleh EV71 
dida/Xlti tidak berbeza daripada sifat-sifat HFMD yang bukon disebabkon oleh EV71. 
Insiden HFMD yang disebabkan oleh EV71 juga dikaji. Kajian ini telah dijalankan ke atas 
bllhu vt11lS yang telah ditunjllkkan positifterhadap enterovirus. Kehadiran EV71 dikesan dengan primer 
~r."...,!!;spesifilt /repada EV71 dengan menggunakon koedah RT-PCR. Daripada keputusan yang diperolehi . 
................... EV71 hanya dike/an dalomjangkomasa April hingga September 1998 dan kodar pengesan EV71 setiap 
bu/on berbezD dari 5% hingga 20%. Secara keseruluhan, kodar pengaringan EV71 sepanjang 
pengawasan j1myakit HFMD hanya 6.7%. Analysis filogenetik yang berdasarkan jujukan nukleotida 
""IlIA: sebahagian daripada gen VPl menunjukkan bahawa EV71 yang telah diasingkon pada 1998 
adalah ah/i /repada 'genogrmlp C '. Kajian terhadap 3 daripada 4 jujllkan nllldeotida yang dimiliki oleh 
Taiwan 1998 EYll mendapati bahawa virus tersebut juga berada di dalam 'genogroup C' manakala 
)'Q1Ig saIU lagi berada di da/am 'genogrmlp B '. Analysis filogenetik unhlk EV71 yang telah diasingkon 
"/IfQSQ wabak HFMD di Sarawak pada 1997 mendapati bahawa virus tni dimiliki oleh 'genogroup B '. 
SIlrawak 1997 EV71 yang diasingkan dari bandar-bandar yang ber/ainan di Sarawak ada/ah serupa dari 
#gi gen_tik dan ia membentuk Huster yang untk di da/am 'genogroup B '. Analysis filogenetik untuk 
EV71 yang diperolehi di Sarawak dan Taiwan juga menunjukkan bahawa perhubungan di antara EV71 
)VlIIg dimiliki oleh genogroup yang ber/Dinan dengan kevintlenan tidak wUjud. 
x 
PTER 1. INTRODUCTION 
.1. PICORNAVIRUSES 
The fiunily of Picornaviridae comprises 9 genera: Rhinovints, Enterovinls. 
vintS, Cardioviros, Hepatovjrus, (Miller, 1997) and 4 newly defined genera, 
eschovirus, Parechovints, Erbovints and Kobuvints (pringle, 1999). The assignment of 
. maviruses into specific genera has depended on the biological and physical properties but 
y, the classification is mainly based on molecular properties of the viruses. The 
cleotide sequences analysis of the member of Enterovints genus has resulted in the 
lassification of porcine enterovirus serotype 1 (PEVI), echovirus 22 (EV22) and echovirus 
(EV23) into new genera. The phylogenetic analysis of the RNA-dependent RNA 
lymerase (Kaku et aI. , 1999), PI and 3D (Doherty et al., 1999) sequences of PEVI has 
wn that PEV-l was distinct from the other members ofEnterovints genus and therefore was 
laced in a new genus Teschovints and renamed porcine teschovirus. EV22 and EV23 have 
so been reDamed parechovirus type 1 and type 2 respectively and assigned to a new genus 
wechovirus (Mayo and Pringle, 1998). The previously unassigned Equine rhinovirus 2 was 
ed Equine rhinitis B virus and has been placed in the genus Erbavirus (Pringle, 1999). 
Yamashita et al. (1998) have shown that a newly identified Aichi virus, an enteric virus 
·ated with human gastroentritis, to be genetically distinct from all picornavirus genera and 
therefore this virus was assigned to new genus Kobllviros (Pringle, 1999). 
1.2. HUMAN ENTEROVIRUSES 
1.2.1. Classification of human enteroviruses 
One of the most important genus in family of Picomaviridae is Enteroviros. The 
member of the Enterovirus genus comprises viruses that infect human and animals. The 
classification of human enteroviruses into groups is based main1y on the virus pathogenicity in 
experimental animals and cytopathology in cell cultures. The enterovirus groups comprise 
polioviruses, coxsackieviruses group A and group B, echoviruses and higher numbered 
eoteroviruses (Table I). There are 66 immunological distinct human enterovirus serotypes 
(MiUer, 1991), but presently EV22 and EV23 have been reclassified into a new genus of 
Parechoviros (Mayo and Pringle, 1998). 
Table 1. The genus Enteroviros (Melnick, 1996a; Miller, 1997) 
_ Group___ _  .___________M_em_---'be~rsO__________ 
Polioviruses PVI-PV3 
Coxsackieviruses group A CAI-CA22, CA24 
Coxsackieviruses group B CB l-CB6 
Echoviruses EV1 ~EV7, EV9, EV} l-EV21, EV24-EV27, EV29-EV33 
Enteroviruses EV types 68-71 
. 
Polio viruses are the first member of enterovirus to be identified and they able 2. Genetic classifl~ati~n ~f 
important causes ofparalytic poliomyelitis. Further search for poliovirus from paralytic dist'8Cleotide sequences (0 ers eel 
cases had led to the discovery of cosackieviruses, which are further divided into two diffen 
groups based on their pathogenicity in newborn mice. Coxsackieviruses group A (CA V) C8IIuste.r Subgroup 
a generalized myositis in the skeletal muscles that results in flaccid paralysis, wh 
co~sackieviruses type B (CBV), in addition to skeletal muscles, are able to affect wider raq CAl(i)
of tissue including brain, spinal cord, liver, heart muscle and exocrine pancreas (Hyypia 
(ii) CA:.Stanway, 1993; Melnick, 1996a). The introduction of cell culture techniques has lead to A 
discovery of another enterovirus group - the echovirus (ECHO =enteric, cythopathog (iii) CA~ 
human, orphan). Echoviruses were not associated with any diseases at the time of the 
discovery, as they did not cause characteristic pathogenicity in experimental animal EV: (i)However, it was later known to cause a wide range of clinical syndromes (Melnick, 1996a).). 

more newly identified enterovirus shared similar properties with enterovirus of differ EV
(ii) 
groups, the task of assigning them to groups become complicated. Therefore, the new! 
(iii) EVidentified enterovirus serotypes have been given numbers in the order of their identificatiOl 
EVfor example enterovirus type 68 to 71 . (iv) 
CB(v)BRecent developments in molecular biology have enabled the analysis of tit 
(vi) Ev 
enterovirus nucleotide and amino acid sequences and such data are becoming more useful· 

the classification of enterovirus. The comparison of amino acid sequences in the PI regiCl (vii) E\ 

between representatives of picornavirus has shown that EV22 and EV23 are genetical~ (viii) E\ 

distinct q-om other enteroviruses and picomaviruses (Hyypia et al., 1997). The comparison 
 unstable subgrouP CJ 
amino acid sequences in the VPl and 2C regions between the representatives of picomaviruse E' 
have also shown the clustering ofEV22 and EV23 into independent genetic cluster (Stanway 
aI., 1994~ Ghazi et aI., 1998). Apart from sharing some similar physical properties with othe 
(i) C.enterovuUses, EV22 and EV23 have other properties atypical of enteroviruses. These includt 
the lack of VPO cleavage and myristoylation and the presence of a unique N-terminai (ii) CC 
extension to VP3 and an arginine-glycine-aspartic acid (RGD) motif in VPl (Stanway et aJ C(iii)
1994; Ghazi e1 01., 1998). On the basis of these molecular and biological characteristics, EV22 
(iv) Cand EV23 have been reclassified into a new genus ofParechovirus (Mayo and Pringle, 1998). 
The phylogenetic analysis of several genomic regions has shown the genetic E 
relationships among human enteroviruses. However in many cases, these relationships are DOl D 
consistent with the classical grouping of enterovirus serotypes based on antibody neutralizatiOll 
tests. The comparison of nucleotide and deduced amino acid sequences in the capsid proteiJ . I 
region (PI), partial sequences of VP4/2 and 3D regions resulted in the grouping of 1.2.2. Physical and chemica 1 
enteroviruses into four major phylogenetic clusters- A. B, C and D (Hyypia et 01., 1997) 
Enteroviruses areHyypia et al. (1997) have suggested that the genotypic cluster C can be further divided into 2 
crystallography bas sho~n tt,subgroups based on the virus interaction with the host cell receptors to separate polioviruset 
5 om thick and 30 om \D dlfrom coxsackieviruses. The comparison of complete VPl sequences of 57 human enterovirus 
CsCl is 1.34 glml a~d thtstrains has also produced 4 major phylogenetic clusters (Oberste et aI., 1999b), which is 
Enteroviruses are relatively consistent with the published enterovirus phylogenetic trees based on the VP2 sequences 
alcohol and lysoi, and deteI (Hyypia et aI., 1997). The enterovirus within each of the 3 major clusters (Table 2) is further 
ultraviolet light and free chi­segregated into distinct subgroups, with cluster A, B, and C have 3, 8 and 4 subgroups 
thermolabile and they respectively (Oberste et 01., 1999b). are 
1996a and 1996b). AnOthl 
condition at pH ~3 (~elll 
replicate in gastromtestmal 
2. Genetic classitication of human enteroviruses based on complete VP I gene 















CA7, CAI4, CAI6 and EV71 
CAJ,CA4,CA6,CA8 and CAlO 
CAS and CAI2 
EV3 and EV12 
EVI iand EVl9 
EV2 and EVIS 
EV13 and EY69 
CBI-CB6 
EVi, EV4 and EV8 
EV6 
EV21, EV2S, EV29 and EV30 
~ unstable subgroup CA9, EVS, EV7, EV9, EVI4,EVI6,EVI7,EVI8, EV20,EV24, 






CAl , CAl9 and CA22 
CA2I, CA24 and EV34 
CAlland CAIS 
CAl3, CAI7, CAI8, CA20, PVI, PV2 and PV3 
shown the genetic 
relationships are not D EV70 and EV68 
neutralization ...-­
in the capsid protein 
the grouping 
et oJ., 1997). 
divided into 2 
~~IA,.",t.. polioviruses 
human enterovirus 
I999b), which is 
VP2 sequences 
(Table 2) is further 
and 4 subgroups 
1.2.2. Physical and chemical properties 
Enteroviruses are small, spherical and non-enveloped RNA viruses. A X-ray 
c;rystallography has shown that the icosadhedral capsid enclosing the RNA genome is roughly 
S run thick and 30 nm in diameter (Rueckert, 1996). The buoyant density of enterovirus in 
ClCI is 1.34 simI and the molecular weight is 8.25 x 106 daltons (Zeichhardt, 1992). 
Eateroviruses are relatively stable viruses, shown by tht:il I'esisiam;e to disinfectants such as 
IIc:ohoI and Iysol, and detergents such as ether and deoxycholate, but rapidly inactivated by 
ullraviolet light and free chlorine residual (Melnick, 1996a and i 996b). Enteroviruses are also 
dIermoIabile and they are destroyed rapidly at 50°C unless stabilized by MgCh (Melnick, 
1996a and I 996b). Another important property of enterovirus is their stability in acidic 
condition at pH ~3 (Melnick, 1996a). This acid stability property enables the viruses to 




associated WIth chromc d 
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3. ENTEROVIRUS INFECT] 1.2.3 . Genome organization 
The enterovirus genome consists of a single stranded positive sense RNA molecule3 .1. Pathogenesis ofenterovir 
approximately 7.5kb in length and a molecular weight of2.6 x 106 daltons (Zeichhhardt, 199: . 
The genome is organized into a 5'nontranslated region (5'NTR), a long polyprotein codi Enteroviruses .gam en 
region, a 3'untranslated region (3'NTR) and a 3'polyA tail (Figure 1). Covalently attached lUtes. Once they are m the ~ 
the 5' end of the genome is a small basic viral protein called VPg protein, which plays acts. In some cases, enterovl 
important role in the initiation of RNA replication (Rueckert, 1996). The 5' and 3'NTRs ach the target ti~su.e s~ch a: 
highly conserved between different enterovirus types and they contain elements essential 'here further multlphc~tlon tal 
efficient RNA replication and translation (Rohll et aI. , 1995; Xiang et at., 1995, RueckCild symptomatic infections, el 
1996, Mirmomeni et aI., 1997). The polyprotein-coding region can be divided into PI, P2 • viruses are generally shed 
P3 regions. The PI region consists of genes that encode 4 viral structural proteins, VPl to V n. 1996; Melnick, 1996a). 
which make up the enterovirus capsid. The sequences of the PI coding region are hig 
varia~le because the viral capsid protein is constantly subjected to pressure caused by h . 
antibodies. The nucleotide sequences in P2 and P3 regions are highly conserved because tht.3.2. Clinical manifestatIOn 0: 
encode viral enzymes that are important in the virus life cycle. During the multiplication I . . . 
enterovirus in cell cytoplasm. the messenger active RNA is immediately translated into a lall EnterOVIrus mfectloOi 
polyprotein by using the host protein synthesis machinery (Rueckert, 1996). The existence be most common ~orms ~f 
this nascent polyprotein is transient as it is rapidly cleaved by viral-coded proteases into vinyndromes are aSSOCIated WIt! 
proteins. The replication of viral RNA is accomplished by viral coded RNA-dependent-RNtsSOCiated with hand, f~~t a 
polymerase. 	 associated with myocardItIS. I 
Ife associated with more tt. 
... X)mmonly caused by CBV2, , 
5'l1tr-<loill~--pl---"'''41---P2--'''''''''''~-- P3 - --"'3'lttr One of the most im~ 
T ~ I ILl.. poliomyelitis caused by P?b 
~Pg~ lAECD 2AEC 3ABCD I po.yf,A)mass vaccination. Non-pobo' 
cause of morbidity and mor 
NPEV isolations w~~e rep! lT rUI$la.ti.:m meningitis, encephahtts, pne 
the most important cause ~f 
serotypes commonly assocla 
EV1 6 and 30 (Rorabaugh e 
has also occurred in vario 
predominant serotype, suC 
switzerland. (IASR., 1998b 
enterovirus include enceph 
fi+~lP2! VP3! vPI ! 
flaccid paralysis and amol 
Myopericarditis, pleurodY1 
Figure 1. Structural organization of enterovirus genome (Melnick, 1996a), The genome is associated with group B 
translated into a long polyprotein, which is then cleaved into individual peptides. The cleavage commonly caused by CA2, 
of polyp rote in is performed by proteinase 2C and 3C or by a precursor form called 3CD. by CA16 and EV71 (Mel 
(Juhela, 1998) and tends tc 
immune system, Amo~g 
myocarditis with or .W1t~( 
serotypes frequently Imph 
Severe enterovirus infect 
patients with. aggam~agl' 
· ENTEROVIRUS INFECTIONS 
.1. Pathogenesis of enteroviruses 
Enteroviruses gain entry into the human body mainly via the oral and respiratory 
Once they are in the host body, they mUltiply in the gastrointestinal and respiratory 
In some cases, enterovirus may enter the blood stream. During this viremic phase they 
the target tissue such as the central nervous system (CNS), heart, muscles and skin, 
further multiplication takes place and resulted in clinical diseases. In both asymptomatic 
HU,,,,,,,,I\.C• .m symptomatic infections, enterovirus can be recovered from the oropharynx and intestine. 
viruses are generally shed for a longer period of time in the stool (Schnurr, 1992; Grist and 
1996; Melnick, 1996a) . 
.....,••.1 .<.. Clinical manifestation of enterovirus infections 
Enterovirus infections can result in a wide spectrum of clinical syndromes. However, 
most common forms of infection are asymptomatic or mild. Several specific clinical 
J~lYI1<lrolnes are associated with certain enterovirus serotypes, for example EV71 and CA 16 are 
lU'IA-'Oe~lenlclerlt-llN.• sociau:d with hand, foot and mouth disease (HFMD) and coxsackieviruses group B are 
The genome is 
W-l'uu,•.,. The cleavage 
called 3CD. 
ltISocuitea with myocarditis. However, there are instances whereby certain clinical syndromes 
aSllDCiated with more than one enterovirus serotypes, for example aseptic meningitis 
a:olnm()nly caused by CBV2, CBS and EV30 (Melnick, I 996a). 
One of the most important clinical manifestations of enterovirus infection is paralytic 
.... 'linm" ..litis caused by polioviruses, but currently, this disease is effectively prevented by 
vaccination. Non-poliovirus enterovirus (NPEV) infections are becoming more important 
of morbidity and mortality. In a NPEV surveillance in the US (1993-1996), 3209 of 
isolations were reported, mainly from patients clinically diagnosed with aseptic 
r. mlemnaitIS. encephalitis, pneumonia, paralysis and carditis (CDC, 1997). Enterovirus is also 
most important cause of aseptic meningitis in young infants and children, and among the 
serotvloes commonly associated with aseptic meningitis are CB2, CBS, EV4, EV6, EV9, EVil, 
EVI6 and 30 (Rorabaugh et aI., 1993; Melnick, I 996a). The epidemic of aseptic meningitis 
has also occurred in various parts of the world, and normally it is caused by a single 
predominant serotype, such as EV30, which responsible for outbreaks in Japan and 
Switzerland. (IASR, 1998b; Gorgievki-Hrisoho et al., 1998). Other CNS diseases caused by 
enterovirus include encephalitis and poliomyelitis-like diseases, paralytic disease and acute 
flaccid paralysis and among the most important cause is EV71 (Alexander et aI., 1994). 
Myopericarditis, pleurodynia, upper respiratory illness and pneumonia are commonly 
associated with group B coxsackievirus infections (Melnick, I 996a). Herpangina are 
commonly caused by CA2, CA6, CA8 and CAlO while hand, foot, and mouth disease (HFMD) 
by CA16 and EV71 (Melnick, 1996a). Enterovirus infection is also common in neonates 
(Juhela. 1998) and tends to result in serious or even fatal diseases due to the immaturity of the 
immune system. Among the serious outcome of enterovirus infections in neonates are 
myocarditis with or without encephalitis, hepatitis, sepsis and pneumonia, and enterovirus 
strotypes frequently implicated are CBS, EV20 and EVil (Galama, 1997, Head et aI., 1999). 
Severe enterovirus infections are also occurred in immunocompromised patients such as 
patients with aggammaglobunaemia and AIDS (GaJama, 1997). Enterovirus has also been 
associated with chronic diseases such as insulin-dependent diabetes mellitus (Hiltunen el ai, 
S 
1997; Graves el aI., 1997), dilated cardiomyopathy (Conaldi el aI. , 1997; Badorff el aI., 1 ~ 
postviral fatigue syndrome and chronic cardiovascular disease (Melnick, 1996a). Nelc 
'Obe 
is h 
lA. LABORATORY DIAGNOSIS OF ENTEROVIRUS INFECTIONS verc 
BPi' 
lA .1. Virus isolation in cell culture NA 
Mel 
The diagnosis of enterovirus infections based on clinical ground alone is not reli d 
as the clinical syndromes may overlap with those caused by bacteria pathogens or otkld 
viruses. Therefore, a laboratory diagnosis is necessary to confirm enterovirus infecti n 
Currently, the diagnosis of enterovirus infections depends on the conventional method of v. e 
isolation in tissue culture. The availability of different cell lines that are sensitive to enterovilOl1l 
enabl~s the isolation of many enterovirus serotypes, except for CA l, CAl9 and CA22, wh' J 
can only be isolated in suckling mice (Gradlen el al., 1989). Among the cell lines used 
isolation of enterovirus are the human rhabdomyosarcoma cells, HeLa cells, human fi* 
diploid kidney cells, green monkey cells and primary monkey kidney cells (Gradlen el 4. 
1989). 
Although sensitive, the utility of tissue culture technique in enterovirus diagnosis 1111 
limited QY several disadvantages. Virus isolation is time-consuming and normally several daJOl 
are required before growth can be detected. Abzug el al., (1995) has shown that after 
inocul'ation of cerebrospinal fluid (CSF), serum, urine, throat and rectal specimens frofo 
neonates onto the monkey kidney, Hep-2, Vero and human lung fibroblast cells, the mean ti~ 
to the earliest positive result for each patient was 4.2 days. Rotbart, (1989) has also reportedD 
mean ar 6.3 days for the isolation of enterovirus from CSF specimens. The slow growth IJf' 
enterovirus in culture might be due to several factors. Among them is the low titer of vinie 
particles or the presence of difficult isolates or mixture of viruses in the clinical specime 
Several subpassages are also necessary before establishing a diagnosis of enterovirus infecti 
to rule out cytotoxic effect of some clinical specimens, which could be mistaken fI 
enterovirus cytopathic effect (CPE). The condition, type and quality of clinical specimens an 
also important to ensure the virus remains viable. The insensitivity of cell line to certaitl 
enterovirus serotypes necessitates the use of multiple cell lines to improve the isolatiOl 
efficiency, a procedure which is expensive and labor intensive. Some enterovirus serotype 
such as CAl, CAl9 and CA22 require isolation in suckling mice and such technique is ~c 
suitable for use in the diagnostic laboratory. The tissue culture technique is also dependent 011 J 
the access of laboratory with tissue culture facilities and requires high level of expertise. Other ( 
methods used for detection of enterovirus in clinical specimens include electron microscopy c 
immunofluorescence and enzyme-immunoassay (Schnurr, 1992; Gradlen et al., 1989). 
Although most enterovirus infections are self-limiting and require no specific therapy, . 
rapid and accurate diagnostic test is required . This is because many enterovirus infections are 
often indistinguishable clinically from other treatable diseases caused by bacteria pathogens, 
and other viruses. The time-consuming procedure in tissue culture technique often results in 
unnecessary or longer hospitalization and unnecessary treatment with antibiotics or expensi e 
antiviral drug such as acyclovir to treat herpes simplex infections. Enterovirus infections may 
also result in severe and potentially fatal diseases, especially in neonates and 
immunocompromised patients where immediate clinical decisions need to be made. Several 
diagnostic techniques have been developed to improve enterovirus diagnosis. Rotbart (1989 
and 1991) has reported a rapid enterovirus diagnosis by using nucleic acid hybridization 
6 
•Badorff el aI., 1YlIII1miI~ue. This technique make use of the conserved sequences existed among enterovirus to 
I996a). broadly reactive probes such as nick-translated cDNA probes, single-stranded RNA 
and oligomeric DNA probes. Although rapid and sensitive, the clinical application of 
hybridization technique is limited by low titer ofvirus in the certain clinical specimens. To 
,,'COOle this. Rotbart (1989 and 1991) employed 'monolayer blot' technique and enzymatic 
..,litic:atic:m of a target region in the enterovirus genome to increase the number of target 
molecules available for hybridization with the probes. Bourlet et 01.• (1998) have 
_~NI'11 a rapid culture assay (RCA) as an alternative to conventional culture assay (CCA) 
detection of enterovirus in stool specimens. The RCA combined an immunoperoxidase test 
group specific anti-VP1monoclonal antibody to detect enterovirus CPE. The anti-VPl 
IDtc~ctjolDaocloJW antibody was specific for a highly conserved epitope in the VPl of most 
vul.rnviimll serotypes. This study bas demonstrated that the sensitivity and specificity of RCA, 
enrero'vUlllD1l1NU'ed to CCA, were 77.9% and 98% respectively. Although rapid and more sensitive than 
Uln_" a RCA is. limited by the stool toxicity, which can reduce the sensitivity ofthe assay. 
Serological diagnosis 
Serological diagnosis plays a limited role in enterovirus diagnosis because of a large 
of serotypes. Therefore, detection of type-specific antibody against enteroviruses is 
da]"npli,callcd by,the lack of a single common antigen and occurrence of heterotypic antibody 
eutralization test is the most common test used to detect type-specific antibody. 
serological diagnosis, a significant increase in antibody titer from acute and convalescent 
L11111_~ sera indicates enterovirus infection. Testing for the presence oftype-specific antibody is 
much easier when a characteristic clinical picture implicates certain serotypes such as 
B coxs8ckieviruses which cause myocarditis. or an epidemic situation caused by one or 
J)Te:vaJ1eot serotypes. The detection of enterovirus-specific IgM is valuable to determine 
Spf~ClTneJIl.fbelther the infection is recent. However, since the background level of IgM may be high the 
......'rn".ft the results ofIgM detection in serum must be interpreted with caution. 
The development of PCR technologies has greatly improved the diagnosis of 
nOilculeroMnJs infections. Its simple procedure, rapidity, sensitivity and specificity have made 
a more attractive and preferable method in enterovirus diagnosis than tissue culture and 
UtJler1lGUlieT methods discussed above. RT-'PCR allows detection of enterovirus directly from the 
"~rOS(;o~tv·..	dinica1 specimens. The knowledge of complete nucleotide sequences of many enterovirus 
.-otypes bas made possible the design of broadly reactive or serotype/strain-specific PCR 
primers which can be used in the detection of enterovirus RNA in clinical specimens as well as 
typing of the enterovirus isolates (Romero and Rotbart, 1993 and 1994), 
A number of studies that compared the performance of RT-PCR assay with viral 
c:uIture have demonstrated that RT-PCR assay is useful for rapid and reliable diagnosis of 
or emerovirus infections. Schlesinger et 01. (1994) have reported that enterovirus was detected in 
infections may CSF by RT-PCR from 11 of 12 infants with definite or probable aseptic meningitis and 6 of 13 
neonates and iII&nts with possible aseptic meningitis. The sensitivity of RT-PCR was further supported by 
made. Several llT-PCR positive resuh in 6 infants in whom the CSF viral cuhures were negative. In the same 
Rotbart (I 989 1IUdy, Schlesinger et al. (1994) have also reported that the application of RT-PCR in the 




a study by Tanel et al. (1996), enterovirus was isolated from the CSF, throat and rei-A Typing of enterovirus 
specimens from 9 of90 children with possible meningitis. Six children had enterovirus isoll 
from CSF, compared to 7 children who had positive CSF RT-PCR. In two children who For the purpose o~ cI 
negative CSF RT-PCR, enterovirus was isolated from throat and rectal swabs. The sensiti'fotYPe is not normall~ carne<t 
and specificity of RT-PCR were 77.8% and 100% respectively, compared to 66.7% by v\le to benefit the patIents. All 
culture alone. Ahmed et al. (1997) have found that the sensitivity and specificity ofCSF ltgnosis, there ~e sev~al ~ 
PCR compared to viral culture for the diagnosis of enteroviral meningitis in infant were 9'~rtant . In a re,,:,ew, MUlr.et 4 
and 94% respectively. In a similar comparison study, 13 (34%) and 25 (66%) of 38 Ckrect identificatIon of pohov. 
specimens collected during a summer outbreak of aseptic meningitis were positive ovirus types, typing of e 
enterovirus by viral culture and peR assay respectively (Yerly et aI., 1996). PeR assay ovirus infections and also 
also shown to be more sensitive and accurate in diagnosing viral CNS infections, w 15 such as the Lim Benyesh· 
include those caused by enterovirus (ChartteIjee, 1999; DeBiasi and Tyler, 1999). In a study Environment (RIVM) pool 
16 enterovirus-infected neonates, Abzug et af. (1995) have shown the combined sensitivity~es (Melnick, 19~6a~. ~ 
serum and urine RT-PCR was 88% compared to that of viral culture, which was 56%. Che.qJiable, its application IS 11ml1 
(1996) has developed a RT-PCR assay using poliovirus-specific primer for rapid detection.isera, time-consuming pr~ 
polioviruses in infected tissue culture fluids and clinical specimens. So far the application bable to identify "unty?eable 
RT-nested PCR in enterovirus diagnosis has not widely used compared to single-step P<\ previously unreco~lzed en 
JeftTey et al. (1997) have employed RT-nested PCR to detect enterovirus in CSF specim otypes in the cl~mc~l sp 
from patients with viral infections of the CNS. Enteroviral RNA was also detected by ne~e of neutralIzatIon aI 
PCR in all 13 throat swabs from patients with upper respiratory symptoms and aatiferent laboratory (Loon et a 
nosocomial infections and in 5 of 6 stool specimens from patients with acute flaccid paral 
(KWlll.l ]997). As a result of these Ii 
aethod oftyping. Rigonan et . 
The recently developed commercialized enterovirus peR test kit from R~y (IFA) using commef 
MoleqJ.lar Systems, Basel, Switzerland (Yerly et al., 1996) has standardized the procedure ~lioviruses and NPEV. Alt~( 
RT-PCR assay in enterovirus diagnosis. The evaluation of this test kit with CSF speci~ctivity of monoclonal anub 
from meningitis patients have demonstrated that the kit was more sensitive than viral cultma also limited . 
(Kessler et aI., 1997; Vliet et aI., 1998; Gorgievski-Hrisoho ef aI., 1998; Pozo et aI., 199f. 
Hadziyannis et aI. , 1999). The test kit is based on a one-step reverse transcription and PCthe application of RT-PCR 
with the incorporation of uracil N-glycosylase to prevent carryover contamination. The use !typing of entero~s. , Ho",,: 
biotinylated primers allows the detection of PCR product using a microwell colorim~uence informatIon IS aVID 
system (Yerly et aI., ] 996). Rotbart (1997) bas determined the reproducibility of ~ protein coding genes ~U< 
enterovirus PCR test with CSF, serum, urine, throat and rectal specimens from patients ~ed PCR using entero~ 
enterovirus infections and found that the reproducibility of this test kit was 991'10. Taggart et alptients with dilated, cardtotT 
(] 998) have reported that the sensitivity and reproducibility of the enterovirus PCR test laies by sequencmg of P 
enhanced with incorporation of commercially available coprecipitant, a polymeric carrier 'mers derived from the VI 
for nucleic acid precipitation., during RNA extraction. 'the pe R products. Arola et 
using primers derived fro 
In addition to enterovirus detection in clinical specimens, RT-PCR has also 'bee&picornavirus genome. By us 
found useful for other purposes. For example, in a study by Byington et aI. (1999), RT-~ on the length of the 
was used for epidemiological investigation of the incidence ofNPEV infections in febrile eaterovirus by sequence a 
afebrile infants. RT-PCR is also used to detect enterovirus RNA in myocardial tissue fro eaterovirus genome have ~e 
patients with dilated cardiomyopathy (Archard et al., 1998) and in formalin-fixed paraffin,! provides a more ~seful 11 
embedded myocardial tissue from patients with acute myocarditis (Nicholson et aI., 1995 ~iticity. Companson 0~ 1 
Behan et al., (1996) have applied RT-PCR to identify the potential role of enterovirus' has shown good correlauc 
initiating autoimmune attack in inflammatory myopathy. A number of reports have al Oberste et al., (1999b) ~avc 
described the application of RT-PCR method for the detection of enterovirus in environm half of VPl and the 5 em 
samples (Lees et aI., 1994; Puig et aI., 1994; Reynolds et aI. , 1996). lDalysis of the 450bp ami 
correlated 100% with E\ 
example, Holland et aI., (' 
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Typing of enterovirus 
For the purpose of clinical diagnosis, the identification of individual enterovirus 
is not nonnally carried out, as the traditional method of neutralization test takes a long 
to benefit the patients. Although typing of enterovirus isolates is not crucial for clinical 
there are several situations whereby identification of enterovirus serotype is 
In a review, Muir et aI. , (1998) has indicated that enterovirus typing is necessary for 
identification of poliovirus, study of enterovirus pathogenicity, identification of new 
.........;..,,~ type&. typing of enterovirus isolated from neonates and patients with chronic 
....".ui...~ infections and also for epidemiological purposes. The availability of intersecting 
such as the Lim Benyesh-Melnick (LBM) and the National Institute of Public Health and 
. (RIVM) pool schemes has made easy the task of identifying most enterovirus 
(Melnick, 1996a). Although enterovirus typing by neutralization test is generally 
its ~plication is limited by several disadvantages. Apart from the limited supply of 
time-consuming procedure, labor intensive and expensive, neutralization test is also 
to identify "untypeable" enterovirus. The "untypeable" enterovirus may be due to a new 
previously unrecognized enterovirus serotypes, the presence of more than one enterovirus 
in the clinical specimens or fonnation of non-neutralizable aggregates. The 
of neutralization also lacks standardization and the results obtained may vary in 
laboratory (Loon et al., 1999). 
As a result of these limitations, a need has arisen to look for a more rapid and reliable 
..ltbcld oftYJ,ing. Rigonan et aI. , (1998) have evaluated the use of indirect immunofluorescent 
(IF A) using commercially available monoclonal antibody for differentiation of 
.w..vin'U!!I and NPEY. Although rapid, this method is less sensitive, and in addition to cross­
monoclonal antibody with other NPEV, the number of enterovirus types identified 
.I.JtUJ. ·a1so limited. 
application of RT -PCR and sequencing of the amplicon is becoming more useful for 
of enterovirus. However this typing method is only limited to viruses for which 
information is available. Serotype-specific PCR primers are nonnally derived from 
protein coding genes such as VPl and VP2. Archard et al., (1998) have employed RT­
PCR using enterovirus group-specific primers to detect enterovirus in myocardium of 
with dilated cardiomyopathy, and this was followed by characterization of enterovirus 
by sequencing of PCR product. Kilpatrick et al., (1998) have used 3 sets of PCR 
derived from the VPl gene to differentiate poliovirus serotypes based on the length of 
PCR products. Arola et aI. , (1996) have reported the application of competitive RT-PCR 
primers derived from the S'NTR and VP2 caspid protein-coding regions of the 
b~~r_COfIlI&vin genome. By using this primer, enteroviruses were differentiated from rhinoviruses 
\..:Jt_ lud 00 the length of the PCR products, and at the same time enable genetic typing of 
811iIl'O'rntJlS by sequence analysis of the PCR products. Although various regions of the 
genome have been used for typing, nucleotide sequence analysis of the VPl region 
provides a more useful information as this region contains important sites for serotype 
.,ecificity. Comparison ofthe complete VP 1 sequences of prototype human enterovirus strains 
Ills shown good correlation between VP1 sequences and serotype (Oberste et al., 1999a). 
et al., (l999b) have designed degenerate deoxyinosine containing PCR primers from 3' 
of VPl and the S'end of 2A for typing of clinical enterovirus isolates, and sequence 
of the 4S0bp amplicon has also shown that the nucleotide sequences of this region 
carrelated 100010 with EV serotype. Other methods of typing has also been reported, for 
.ample, HoUand et aI., (1998) have developed a technique of viral protein fingerprinting for 
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differentiation and characterization of clinical enterovirus isolates based on the unique proAfrica (WHO, 1996). ~o~e' 
patterns of each serotype. RT-nested PCR followed by restriction fragment I mic regions. For e~~p e, ~: 
polymorhism (RFLP) analysis has also been used for typing of enterovirus directly from\'&Ccinated ~nd, partir y /a 
clinical specimens (Kuan., 1996), IIlstant momtonn~ 0, po ~omi 
wards global eradicatIOn 0 ~ I 
hie indicator of eradlcatrel' 	 'la 	 , 
1.5. CONTROL OF ENTEROVIRAL DISEASES 	 mptomatic. Therefore It IS ~er: 
YviTological monitoring. Vuo 
Currently there is no antiviral drug available for prevention and treatment of hutWticular EV:l, ~s .the~ :btl: 
enteroviral diseases. A new anti-picornavirus drug called pleconaril is stil\ under research e clinically mdlstmgUls ~he 
it has been shown to have inhlbitory against most enterovirus strains in cell culture (peveqccioe available ~o p~eventf~h 
aI., 1999). The only method to prevent enteroviral diseases is through public health act" 'go. However m vle7 0 :tl 
such practice of good hygiene, improved sanitation and standard of living and epidemiol~e is a reason to deve op an 
surve~lance of potentially life-threatening enteroviral diseases. Vaccination is one of the III 
effective ways of preventing enterovirus infection., but the only vaccine available is 
poliovirus. 
The current poliovirus vaccines in use are live, attenuated oral poliovirus (OP' 
vaccine and inactivated poliovirus vaccine (IPV). These vaccines contain all 3 poliovill 
serotypes. The OPV vaccine has been used more widely due to its easy administration., 10 
cost and, ability to induce intestinal immunity and long-lasting immunity (Modlin, 199 
Melnick, 1996a). The OPV viruses are shed in the feces by vaccinees and spread to 
unvacdnated contacts. Such transmission of OPV viruses is considered to be advantagea 
because high vaccine coverage can be achieved especially in area with low vaccine acceptant 
levels. However, the transmission of OPV viruses to unimmunized contacts is potentially ri 
as they ban revert to virulent strains and cause vaccine-associated poliomyelitis. This happent 
in the USA, where 125 of the 133 confinned cases of paralytic poliomyelitis were vaccine 
associated paralytic poliomyelitis (VAPP) (CDC, 1 999b). Unlike OPV, the eIPV contains 
living viruses and therefore it is recommended for immunodeficient persons as well I 
unvaccinated adults (Modlin, 1996). IPV can be incorporated with a diptheria-tetanus-pertu 
ir. 	 • (DTP) vaccine and since living viruses are absent, there is no risk of getting vaccine-associat 
poliomyelitis. Despite these advantages, IPV is not widely used especially in developiq 
countries because of its expensive cost and inability to induce intestinal immunity effective~ 
as OPV vaccines. The absence of secretory antibody allows wild type poliovirus to multiply ' 
the gastrointestinal tract of vaccinees which later are transmitted to unvaccinated conta~ 
(Melnick, 1996a). Therefore, IPV fails to block the transmission of wild polioviruses by fecal­
oral route. 
An alternative strategy of vaccination which involved a sequential administration d 
IPV and OPV has been recommended to prevent V APP among recipients and to reduce tht 
risk of OPV viruses transmission to immunocompromised individuals (Modlin, 1996). WiD 
the implementation of this new vaccination schedule (CDC, 1999b) and the increased 
capability to diagnosed non-polio enterovirus (NPEV) paralysis, the incidence of V APP is 
reported to be decreasing (Sepkowitz, 1997). 
In 1988, the World Health Organization (WHO) aimed to eradicate poliomyelitil 
globally by the year 2000 (WHO, 1988) by mass vaccination. As a result, the number ri 
poliomyelitis cases has greatly reduced. Presently wild polioviruses have been successfully 
eradicated from the region of America by vaccination, and the effort to eradicate wild 
poliovirus is still in progress in the endemic regions such as Europe, Asia and several countries 
]0 
on the unique 
.m'.... r.ft fragment 
directly from 
(WHO, 1996). However, outbreaks of poliomyelitis commonly occur in these 
regions. For example, in Angola in 1999, an outbreak of poliomyelitis has occurred in 
lIc<:inattld and partially vaccinated children and resulted in 39 deaths (CDC, 1999a). 
monitoring of poliomyelitis cases is important in order to evaluate the progress 
global eradication of poliomyelitis. However the absence of poliomyelitis cases is not 
indicator of eradication as the most common infections by poliovjruses are 
!IIP1DDllW.C. Therefore it is very important that the evaluation of eradication is accompanied 
m llogical monitoring. Virological monitomg is also important to exclude NPEV, in 
1, as they are able to cause paralytic disease and acute flaccid paralysis, which 
rcliDjcally indistinguishable from poliomyelitis caused by poliovirus. To date, there is no 
available to prevent other enteroviral diseases since most of them are self-limiting and 
However in view of the recent increase in EV71 outbreaks in several regions in Asia, 
i8 a reason to develop an effective vaccine against EV7l. 
11 
. 
lUll. must be interpreted careft CHAPTER 2. STATEMENT OF PROBLEM 
ry be high. In a surveillance 
(71 has been shown as an I 
Ill's palsy, acute cerebellar atl 
2.1. HAND, FOOT AND MOUTH DISEASE 	 Outbreaks of EV71 inl 
urological diseases including 
Hand, foot, and mouth disease (HFMD) is a common acute viral illness that prim. e been reported. In an outb~ 
affects young chi ldren and infants. HFMD has been reported to occur in outbreaks or epid lated were EV71 . The rnaJ 
in various parts of the world. The disease is usually mild and self-limiting. After an incubapgitis (Blomber~ et al.,. ~ 
period of 4 to 6 days following exposure of the virus to an individual, the patient will begif75 where pohomyehtJi 
have fever and sore throat. About 2 days after the appearance of initial symptoms, small ~pbalomyocarditis were t~ 
superficial ulcers develop rapidly from vesicles on the gum, tongue, buccal mucosa and pal eloped paralysis, and 44 Oi 
A d;l.y or two after that, smalJ red spots, which eventually tum into vesicles, appear on Ie1nick, 1996a). A large:-sca1 
palms of hands, soles of feet, buttocks, axillae or other areas. The skin lesions may be fe\\'fedominant clinical marufest: 
number. Fever and skin rash usually subside rapidly, but uJcers may last more than a weekjth clinical features such as 
patient with HFMD is contagious when the first symptoms appear and continue to shed viru.,se cases were fatal (Nagy, 
the stool for up to several weeks even after the disappearance of the symptoms. (Grist and B6seases have also been repor1 
1996; Melnick, 1996a) The virus is mainly spread by direct contact with respirat 7 (Alexander. et a/:, 199 
discharges, weeping vesicles and feces of the infected people, and outbreaks may occutJUfological manJfestatl~ns \\ 
overcr~wding and conditions of poor hygiene. xcept for that in Bulgana an 
1fMI), for example in Japan 
Currently, there is no specific antiviral treatment for HFMD. Treatment is aimedlFMD have been in Sarawa 
relieving fever and sore in the mouth. Practicing ofpreventive measures such as good persctLuro, et aI., 1998a ~d .199: 
hygie,ne is important to prevent the spread of the disease and potentiaJ outbreak fi1erth, Western AustralIa to 1 ~ 
occurring. The affected individual normaHy develops specific immunity after the infection . 
a particular enterovirus serotype, but recurrent infection with differenl enterovirus serotyJ) In Malaysia, HFMD 
may occur (Melnick, 1996a). Laboratory diagnosis of HFMD is rarely performed and , mild disease that can be .m~ 
usually unnecessary due to the mild nature of the disease and the expense and length of tillo the assessment of the mCI 
needed to perform the tests. The diagnosis is generally based upon the appearance ~ence of a clu~er of pe 
characteristic vesicles on hands and feet, ulcers in the mouth and mild fever. associated HFMD to Saraw 
presented with severe neuro 
The major causative agents of HFMD are CA16 and EV7l. Several 0 Cardosa et aI., 1999). Altho 
enteroviruses such as CA4, AS, A9, AI0, B2 and BS are also known to cause HFMD ( . suggestion that EV71 v 
and Bell, 1996; Melnick, 1996a;) but they are much less frequently associated with HF °th the isolation of subgem 

compared to CA16 and EV71. In an epidemiological surveillance in Japan (1982-1997), CAlrquestion of whether EV71 .
 
and EV71 were reported as the main agents ofHFMD and in 1995 CA16 was responsible fonoutbreak ofEV71 HFMD III 

large-scale epidemic (lASR, 1998a). In the USA, CA16 was also reported as the agent mcJ(occurred (Ho, et al., 1999; I 

probably responsible for regional outbreaks ofHFMD in 1989 (CDC, 1990). HFMD caused 

CA 16 is not associated with complications involving the CNS. However in rare c~ 

infection with EV71 can cause meningitis, encephalitis or a poliomyelitis-like flaccid paraJy . 2.2. OBJECTIVES OF PR( 

(Alexander el aJ., 1994). 

prior to the 1991 
EV71 is first described in 1974 from patients in California who had se~ Sarawak, and therefore the 
neurological disease during an outbreak of CNS diseases between 1969 and 1973 (Melni etiology of death has ne~el 
1996a). Since its discovery, EV71 has been known to cause a variety of clinical syndrom about the real or perce.lvi 
among which are HFMD, aseptic meningitis, encephalitis, acute flaccid paralysis (AFP) concern among t~e pubhc 
poliomyelitis-like diseases (Melnick, 1996a). A study by Silva et af. (1996) has bas lmplem~ 
EV71 with AFP-like poliomyelitis in Brazil after the detection of EV71 IgM in 20 of the March 1998. This survetl 
patients with AFP. Since asymptomatic infection is the most common form of infection, 
12 
must be interpreted carefully because the background level of IgM in general population 
be high. In a surveillance for EV7l infection in children in Brazil from 1988 to 1990, 
I has been shown as an etiological agent of acute neurological diseases such as AFP, 
palsy, acute cerebellar ataxia and Guillain-Barre syndrome (Takimoto et aI., 1998). 
Outbreaks ofEV7l infection have occurred in various parts of the world where severe 
",rolc~c81 diseases including aseptic meningitis, encephalitis and poliomyelitis-like diseases 
illness that prima. R beeD reported. In an outbreak in Southern Sweden in 1973, 195 of 300 enterovirus strains 
outbreaks or were EV71. The majority of patients from which EV7l was isolated had aseptic 
After an (Blomberg et aI., 1974). During a severe outbreak of CNS disease in Bulgaria in 
patient will where poliomyelitis-like diseases, meningitis., meningoencephalitis and 
..rr,e,~ba:lorrlyocarditl·is were the main clinical syndromes manifested, 149 of 705 patients 
paJ i_~otOed paralysis, and 44 of 149 patients who had paralysis died (Chumakov, et aI., 1979, 
.alni.c:k, ~a). A large-scale EV71 outbreak also occurred in Hungary in 1978 where the 
. 1d00rninant clinical manifestation was aseptic meningitis. There were 724 encephalitis cases 
clinical features such as acute cerebellar ataxia and poliomyelitis-like disease, and 45 of 
cases were fatal (Nagy, et aI., 1982). The EV7l outbreaks with manifestation of CNS 
have also been reported in Australia in 1972 (Kennett et aI., 1974) and in the USA in 
(Alexander et aI., 1994). In all of these outbreaks, a large number of cases with 
"U'ClloA~ca1 manifestations were recorded and generally it was not linked with high mortality 
for that in Bulgaria and Hungary. EV7l has also been associated with the outbreak of 
_ r for example in Japan in 1978 (Miwa et aI., 1980). The most recent outbreaks ofEV71lYlIU 
have been in Sarawak in 1997 (Cardosa, el aI., 1999), Peninsular Malaysia in 1997 
perSOll• .um, el aI., 1998a and 1998b), Taiwan in 1998 (Ho, et al., 1999; Huang et aI., 1999) and 
fra" !rtIt W~em Australia in 1999 (McMinn, unpublished). 
In Malaysia, HFMD had not been considered to be a public health problem since it is 
mild disease that can be managed as outpatient. For this reason little attention has been given 
the assessment of the incidence of the HFMD. However this perception changed after the 
~tcClJlTence of a cluster of pediatric deaths against a background of a large outbreak of E\l71­
lusociated HFMD in Sarawak. in mid 1997 (Cardosa, et aI., 1999). The children who died 
" :eselrrted with severe neurological disease and cardiac dysfunction, some with HFMD rashes 
otlJtl(Cardosa el aI., 1999). Although the isolation of EV7l from some of these fatal cases has led to 
suggestion that EV7l was the cause of death, the unusual clinical presentation together 
'M..,Mth the isolation of subgenus B adenovirus from fatal cases (Cardosa et aI., 1999) has raised a 
l. p llion of whether EV7l is the on1y etiological agent responsible for the deaths. During an 
.... Jth".jI!r ofEV71 HFMD in Taiwan in 1998, similar clinical presentation in the fatal cases also 
motl~lICQIrred (Ho, el al., 1999; Huang et aI. , 1999). 
2.2. OBJECTIVES OF PROJECT. 
Prior to the 1997 outbreak., there is no published data on the EV7l infection in 
<il"~'_ _ Sarawak, and therefore the epidemiological picture ofEV7l HFMD is unknown. Although the 
etiology of death has never been satisfactorily proven due to EV7l, the public is apprehensive 
~vrutr'''''''''A. l· 1bout the real or perceived life-threatening nature of EV7l HFMD. Due to an increased 
birSlh,cjc .COJM:eI1l among the public as well as the professional about EV71 HFMD, the Sarawak: Health 
~U\;lau:_ Department has implemented a sentinel clinic system for HFMD surveillance beginning in 
March 1998. This surveillance project involved the participation of seven sentinel clinics in 
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